C. M. Johannessen, L. A. Johnson, and F. Piccioni, A melanocyte lineage program confers resistance to MAP kinase pathway inhibition, Nature, vol.504, issue.7478, pp.138-180, 2013.

J. Muller, O. Krijgsman, and J. Tsoi, Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma, Nat Commun, vol.5, p.5712, 2014.

Y. Cheli, S. Giuliano, and N. Fenouille, Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells, Oncogene, vol.31, pp.2461-70, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02530643

M. Ohanna, Y. Cheli, and C. Bonet, Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype, Oncotarget, vol.4, issue.12, pp.2212-2236, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02530603

M. Ohanna, S. Giuliano, and C. Bonet, Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS), Genes Dev, vol.25, issue.12, pp.1245-61, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530715

K. S. Hoek and C. R. Goding, Cancer stem cells versus phenotype-switching in melanoma

, Pigment Cell Melanoma Res, vol.23, issue.6, pp.746-59, 2010.

S. Giuliano, Y. Cheli, and M. Ohanna, Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas, Cancer Res, vol.70, issue.9, pp.3813-3835, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-02530789

T. Strub, S. Giuliano, and T. Ye, Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, vol.30, issue.20, pp.2319-2351, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530755

C. Bertolotto, F. Lesueur, and S. Giuliano, A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, issue.7375, pp.94-102, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00719536

S. Yokoyama, S. L. Woods, and G. M. Boyle, A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, issue.7375, pp.99-103, 2011.

H. Davies, G. R. Bignell, and C. Cox, Mutations of the BRAF gene in human cancer, Nature, vol.417, issue.6892, pp.949-54, 2002.

C. Michaloglou, L. C. Vredeveld, and M. S. Soengas, BRAFE600-associated senescencelike cell cycle arrest of human naevi, Nature, vol.436, issue.7051, pp.720-724, 2005.

T. Kuilman, C. Michaloglou, and L. C. Vredeveld, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, vol.133, issue.6, pp.1019-1050, 2008.

L. C. Vredeveld, P. A. Possik, and M. A. Smit, Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis, Genes Dev, vol.26, issue.10, pp.1055-69, 2012.

A. S. Mcneal, K. Liu, and V. Nakhate, CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma, Cancer Discov, vol.5, issue.10, pp.1072-85, 2015.

P. B. Gupta, C. Kuperwasser, and J. P. Brunet, The melanocyte differentiation program predisposes to metastasis after neoplastic transformation, Nat Genet, vol.37, issue.10, pp.1047-54, 2005.

R. A. Sturm, C. Fox, and P. Mcclenahan, Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients, J Invest Dermatol, 2013.

E. V. Sviderskaya, V. C. Gray-schopfer, and S. P. Hill, p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression, J Natl Cancer Inst, vol.95, issue.10, pp.723-755, 2003.

D. Dankort, D. P. Curley, and R. A. Cartlidge, Braf(V600E) cooperates with Pten loss to induce metastatic melanoma, Nat Genet, vol.41, issue.5, pp.544-52, 2009.

W. E. Damsky, D. P. Curley, and M. Santhanakrishnan, beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas, Cancer Cell, vol.20, issue.6, pp.741-54, 2011.

V. Delmas, F. Beermann, and S. Martinozzi, Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development, Genes Dev, vol.21, issue.22, pp.2923-2958, 2007.

P. Laurette, T. Strub, and D. Koludrovic, Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells, Elife, vol.4, 2015.

V. Pogenberg, M. H. Ogmundsdottir, and K. Bergsteinsdottir, Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF

, Genes Dev, vol.26, issue.23, pp.2647-58, 2012.

B. Bressac-de-paillerets, F. Lesueur, and C. Bertolotto, A germline oncogenic MITF mutation and tumor susceptibility, Eur J Cell Biol, 2013.

G. Mehta, S. Kumarasamy, and J. Wu, MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy, J Mol Cell Cardiol, vol.88, pp.101-111, 2015.

K. A. Wilkinson and J. M. Henley, Mechanisms, regulation and consequences of protein SUMOylation, Biochem J, vol.428, issue.2, pp.133-178, 2010.